EUVIMEDEUVIMED entdecken
Crossref

UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases

Yung-Sung Yeh, Ming-Xia Wu, Meng-Lin Huang, Se-Fen Chang, Chin-Fan Chen, Huang-Ming Hu, Jaw-Yuan Wang

Biomarkers and Genomic Medicine · 2013

DOI: 10.1016/j.bgm.2013.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomarkers and Genomic Medicine, 2013. Verfasst von Yung-Sung Yeh und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yeh, Y., Wu, M., Huang, M., Chang, S., Chen, C., Hu, H., & Wang, J. (2013). UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases. Biomarkers and Genomic Medicine. https://doi.org/10.1016/j.bgm.2013.08.005

Vancouver

Yeh Y, Wu M, Huang M, Chang S, Chen C, Hu H, et al. UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases. Biomarkers and Genomic Medicine. 2013. doi:10.1016/j.bgm.2013.08.005

BibTeX
@article{Yeh2013,
  author = {Yeh, Yung-Sung and Wu, Ming-Xia and Huang, Meng-Lin and Chang, Se-Fen and Chen, Chin-Fan and Hu, Huang-Ming and Wang, Jaw-Yuan},
  title = {UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases},
  journal = {Biomarkers and Genomic Medicine},
  year = {2013},
  doi = {10.1016/j.bgm.2013.08.005}
}
Kostenlos starten →